HappeningToo topic
Polyethylene Glycol 3350 reports
Browse community reports connected to Polyethylene Glycol 3350. These reports can show that other people are describing similar experiences, but they do not prove that Polyethylene Glycol 3350 caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
38 problems
Abdominal Discomfort while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and abdominal discomfort appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and abdominal distension appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and abdominal pain upper appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and abdominal pain appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and acid reflux appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and anxiety appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and back pain appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and constipation appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and cough appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and decreased appetite appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and dehydration appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and diarrhea appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and dizziness appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and dry mouth appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and dyspepsia appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and fatigue appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and feeling abnormal appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flatulence while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and flatulence appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and headache appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and hypotension appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and insomnia appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and itching appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and malaise appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and muscle spasms appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and muscular weakness appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and nausea appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and pain appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and peripheral swelling appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and rash appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and shortness of breath appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and skin redness appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and sleepiness appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Taste changes while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and taste changes appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and tremor appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and vomiting appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and weakness appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and weight decreased appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Polyethylene Glycol 3350
FDA FAERS contains adverse-event reports in which Polyethylene Glycol 3350 and weight increased appear together. This does not establish that Polyethylene Glycol 3350 caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →